Beta-Nicotinamide Mononucleotide

ʻO kekahi inoa: β-Nicotinamide Mononucleotide; β-NMN
CAS NO .: 1094-61-7
Ke Kumu Molekala: C11H15N2O8P
Molecular Weight: 334.22
Nānā: Pauka keʻokeʻo

ʻO nā hopena nui o NMN penei:
* Anti-oxidation
* Hoʻopau i ka emi ʻana o ke kino
* Hoʻoponopono DNA
* Kākoʻo i nā hopena neuroprotective
* Hoʻomaikaʻi i ka hana naʻau a pale i ka puʻuwai
* Hoʻonui i ke kūlana o nā maʻi o Alzheimer

ʻO ka wehewehe ʻana e pili ana i ka Beta-Nicotinamide Mononucleotide
He kuleana koʻikoʻi ka Beta-Nicotinamide Mononucleotide i ka ikehu o ke kino kanaka i hana ʻia, ua komo i loko o intracellular NAD (nicotinamide adenine dinucleotide, cell energy conversion important coenzyme) synthesis. ka palekana, ka mai pinepine.
He kuleana koʻikoʻi ka Beta-Nicotinamide Mononucleotide i ka hana ʻana o ka ikehu cell kanaka, kahi i komo i ka synthesis o intracellular NAD (nicotinamide adenine dinucleotide, he coenzyme koʻikoʻi no ka hoʻololi ʻana o ka ikehu cell).
ʻO ka Beta-Nicotinamide Mononucleotide kahi substrate synthetic o ka coenzyme I, i lilo i coenzyme I (NAD) ma hope o ka adenosylated e nicotinamide nucleotide adenosyltransferase. in vivo β- ʻO ke kiʻekiʻe o ka nicotinamide mononucleotide a me ka hana o ka nicotinamide nucleotide adenosine transferase (Nampt) pili pono i ka neʻe ʻana o NAD β- Nicotinamide mononucleotides e komo pololei i ka adenosine transfer in vivo, a he mau substrates synthetic koʻikoʻi a me nā regulators hana i loko o vivo. I ka ʻōlelo o ka noi therapeutic, hiki ke hoʻohana ʻia ʻo Beta-Nicotinamide Mononucleotide no ka anti-aging, mālama i nā maʻi maʻi, etc. No laila, loaʻa i ka Beta-Nicotinamide Mononucleotide kahi manaʻo noiʻi ākea i ka mālama ʻana i ka lāʻau lapaʻau, a loaʻa nō hoʻi kahi mākeke ākea ākea i ka ʻoihana kemika ma ke ʻano he substrate.
ʻO ka Beta-Nicotinamide Mononucleotide kahi mea i loko o ke kino o nā cell, a ʻo kona palekana ma ke ʻano he huahana mālama olakino he kiʻekiʻe, a ʻo NMN kahi mole monomer, ʻike ʻia ka hopena anti-aging.
Hiki ke hoʻomākaukau ʻia ʻo Beta-Nicotinamide Mononucleotide e ka hū fermentation, chemical synthesis a i ʻole in vitro enzymatic catalysis. Hoʻohana nui ia i ka ʻoihana mālama olakino.
ʻO ka β-Nicotinamide mononucleotide (NMN) he substrate synthetic o ka coenzyme I, i lilo i coenzyme I (NAD) ma hope o ka adenosylated e nicotinamide nucleotide adenosyltransferase. in vivo β- ʻO ke kiʻekiʻe o ka nicotinamide mononucleotide a me ka hana o ka nicotinamide nucleotide adenosine transferase (Nampt) pili pono i ka neʻe ʻana o NAD β- Nicotinamide mononucleotides e komo pololei i ka adenosine transfer in vivo, a he mau substrates synthetic koʻikoʻi a me nā regulators hana i loko o vivo. Ma ke ʻano o ka noi therapeutic, hiki ke hoʻohana ʻia ka β-Nicotinamide mononucleotide no ka anti-aging, ka mālama ʻana i nā maʻi maʻi, etc. No laila, loaʻa i ka β-Nicotinamide mononucleotide kahi manaʻo ākea ākea i ka mālama ʻana i ka lāʻau lapaʻau, a loaʻa nō hoʻi kahi mākeke ākea ākea i ka ʻoihana kemika ma ke ʻano he substrate.